X

Health Sector India

Glenmark Pharmaceuticals Q3 FY26 Revenue Rises 15.1% on Strong Domestic and North American Growth

Glenmark Pharmaceuticals Ltd. (NSE: GLENMARK) reported consolidated revenue of ₹39,006 million for the third quarter ended December 31, 2025, a…

India’s 2026–27 budget outlines health workforce expansion, care services and medical tourism hubs

India’s federal budget for 2026–27 announced a series of measures for the health sector, focusing on expanding the healthcare workforce,…